To be contradicted by facts - it would be helpful to start with some facts of your own.
You are welcome to voice your opinion - but dont expect others to do the digging on obvious numbers which contradict your position.
FACT is that Neuren have stated - in all three PhII trials - "meaningful" improvements, which for any Bio would warrant exploring PHIII trials.
Keen to hear your facts which contradict why the results arent great.
Share Price, page-11167
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.94 |
Change
-0.290(1.79%) |
Mkt cap ! $2.037B | |||
| Open | High | Low | Value | Volume |
| $16.33 | $16.37 | $15.78 | $10.73M | 671.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1500 | $15.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.02 | 1422 | 2 |
View Market Depth
| Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |